These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 34276700)

  • 1. Targeting Mitochondrial-Derived Reactive Oxygen Species in T Cell-Mediated Autoimmune Diseases.
    Chávez MD; Tse HM
    Front Immunol; 2021; 12():703972. PubMed ID: 34276700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea EGCG, T cells, and T cell-mediated autoimmune diseases.
    Wu D; Wang J; Pae M; Meydani SN
    Mol Aspects Med; 2012 Feb; 33(1):107-18. PubMed ID: 22020144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of T Cell Activation and Differentiation by Extracellular Vesicles and Their Pathogenic Role in Systemic Lupus Erythematosus and Multiple Sclerosis.
    Ulivieri C; Baldari CT
    Molecules; 2017 Feb; 22(2):. PubMed ID: 28157168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced Th17 differentiation and aggravated arthritis in IEX-1-deficient mice by mitochondrial reactive oxygen species-mediated signaling.
    Zhi L; Ustyugova IV; Chen X; Zhang Q; Wu MX
    J Immunol; 2012 Aug; 189(4):1639-47. PubMed ID: 22798682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of redox status of peripheral blood on immune signature of circulating regulatory and cytotoxic T cells in streptozotocin induced rodent model of type I diabetes.
    Anupam K; Kaushal J; Prabhakar N; Bhatnagar A
    Immunobiology; 2018 Oct; 223(10):586-597. PubMed ID: 30017263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp
    Ferreira RC; Castro Dopico X; Oliveira JJ; Rainbow DB; Yang JH; Trzupek D; Todd SA; McNeill M; Steri M; Orrù V; Fiorillo E; Crouch DJM; Pekalski ML; Cucca F; Tree TI; Vyse TJ; Wicker LS; Todd JA
    Front Immunol; 2019; 10():2606. PubMed ID: 31781109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactive oxygen species formation and its effect on CD4
    Shu P; Liang H; Zhang J; Lin Y; Chen W; Zhang D
    Front Immunol; 2023; 14():1199233. PubMed ID: 37304262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Remodeling of T-cell mitochondrial metabolism to treat autoimmune diseases.
    Lin L; Ren R; Xiong Q; Zheng C; Yang B; Wang H
    Autoimmun Rev; 2024 Jun; 23(6):103583. PubMed ID: 39084278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease.
    Afzali B; Lombardi G; Lechler RI; Lord GM
    Clin Exp Immunol; 2007 Apr; 148(1):32-46. PubMed ID: 17328715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
    Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
    Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Reactive Oxygen Species and Type 1 Diabetes.
    Chen J; Stimpson SE; Fernandez-Bueno GA; Mathews CE
    Antioxid Redox Signal; 2018 Nov; 29(14):1361-1372. PubMed ID: 29295631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose IL-2 therapy in autoimmune diseases: An update review.
    Zhang R; Zhao Y; Chen X; Zhuang Z; Li X; Shen E
    Int Rev Immunol; 2024 May; 43(3):113-137. PubMed ID: 37882232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactive oxygen species are required for driving efficient and sustained aerobic glycolysis during CD4+ T cell activation.
    Previte DM; O'Connor EC; Novak EA; Martins CP; Mollen KP; Piganelli JD
    PLoS One; 2017; 12(4):e0175549. PubMed ID: 28426686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine tuning subsets of CD4
    Zhao Z; Zhang X; Su L; Xu L; Zheng Y; Sun J
    Int Immunopharmacol; 2018 Mar; 56():269-276. PubMed ID: 29414661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promotion and prevention of autoimmune disease by CD8+ T cells.
    Gravano DM; Hoyer KK
    J Autoimmun; 2013 Sep; 45():68-79. PubMed ID: 23871638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of T cells in the pathogenesis of systemic lupus erythematous: Focus on immunometabolism dysfunctions.
    Saadh MJ; Kazemi K; Khorramdelazad H; Mousavi MJ; Noroozi N; Masoumi M; Karami J
    Int Immunopharmacol; 2023 Jun; 119():110246. PubMed ID: 37148769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunometabolism and systemic lupus erythematosus].
    Xiao YB; Guo MY; Zuo XX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging views of mitophagy in immunity and autoimmune diseases.
    Xu Y; Shen J; Ran Z
    Autophagy; 2020 Jan; 16(1):3-17. PubMed ID: 30951392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Emerging Epigenetic Role of CD8+T Cells in Autoimmune Diseases: A Systematic Review.
    Deng Q; Luo Y; Chang C; Wu H; Ding Y; Xiao R
    Front Immunol; 2019; 10():856. PubMed ID: 31057561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease.
    Sakaguchi S; Ono M; Setoguchi R; Yagi H; Hori S; Fehervari Z; Shimizu J; Takahashi T; Nomura T
    Immunol Rev; 2006 Aug; 212():8-27. PubMed ID: 16903903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.